Valsartan/Hydrochlorthiazid Actavis 160 mg / 12.5 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

valsartan/hydrochlorthiazid actavis 160 mg / 12.5 mg

actavis group ptc ehf - valsartan / hydroklortiazid - tablett, filmdrasjert - 160 mg / 12.5 mg

Valsartan/Hydrochlorthiazid Actavis 160 mg / 25 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

valsartan/hydrochlorthiazid actavis 160 mg / 25 mg

actavis group ptc ehf - valsartan / hydroklortiazid - tablett, filmdrasjert - 160 mg / 25 mg

Valsartan/Hydrochlorthiazid Actavis 320 mg / 12.5 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

valsartan/hydrochlorthiazid actavis 320 mg / 12.5 mg

actavis group ptc ehf - valsartan / hydroklortiazid - tablett, filmdrasjert - 320 mg / 12.5 mg

Valsartan/Hydrochlorthiazid Actavis 320 mg / 25 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

valsartan/hydrochlorthiazid actavis 320 mg / 25 mg

actavis group ptc ehf - valsartan / hydroklortiazid - tablett, filmdrasjert - 320 mg / 25 mg

Kaleorid 750 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

kaleorid 750 mg

karo pharma ab - kaliumklorid - depottablett - 750 mg

Valsartan Krka 320 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

valsartan krka 320 mg

krka sverige ab - valsartan - tablett, filmdrasjert - 320 mg

Kaliumklorid EQL Pharma 750 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

kaliumklorid eql pharma 750 mg

eql pharma ab - kaliumklorid - depottablett - 750 mg

CoAprovel 300 mg / 25 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

coaprovel 300 mg / 25 mg

orifarm as - irbesartan / hydroklortiazid - tablett - 300 mg / 25 mg

Galvus ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

galvus

novartis europharm limited - vildagliptin - diabetes mellitus, type 2 - legemidler som brukes i diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Glyxambi ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

glyxambi

boehringer ingelheim international gmbh - empagliflozin, linagliptin - diabetes mellitus, type 2 - legemidler som brukes i diabetes - glyxambi, fast dose kombinasjon av empagliflozin og linagliptin, er indisert hos voksne i alderen 18 år og eldre med type 2 diabetes mellitus:for å bedre glykemisk kontroll når metformin og/eller sulphonylurea (su) og en av de monocomponents av glyxambi ikke gir tilstrekkelig glykemisk kontroll, når du allerede blir behandlet med gratis kombinasjon av empagliflozin og linagliptin.